Neurovascular device company Imperative Care (Campbell, Calif.) said today that it has completed the initial closing of an $85 million Series C financing round to support the commercial launch of its portfolio.
The round was co-led by new investors Ally Bridge Group and Bain Capital Life Sciences. Existing investors Ascension Ventures, Delos Capital, Rock Springs Capital, 3H Health Investment and Incept also participated in the round. Ally Bridge founder Frank Yu and Bain Capital managing director Andrew Hack, M.D., will join Imperative Care’s board of directors.
“We are thrilled to have Ally Bridge and Bain Capital leading this round of financing at this important stage in our company’s growth,” said Imperative care CEO Fred Khosravi in a news release. “We look forward to Frank and Andrew’s support and guidance as we continue to propel forward Imperative Care’s unique mission. This is an exciting time for our company.”
Imperative Care said it is poised to launch the industry’s first large distal platform access technology and its Zoom aspiration system, which won FDA clearance in May. The Zoom system includes reperfusion catheters, aspiration pump, canister and aspiration tubing. It is designed for use in revascularizing patients with acute ischemic stroke secondary to intracranial large vessel occlusive disease within eight hours of symptom onset.
The company said it is also developing other stroke-care devices.
